Pregabalin: what the patent litigation means for doctors and drug companies
- Posted
- 7 Jun 2018
- Authors
- Ben Goldacre
- Darren Smyth
- Richard Croker
- Citation
- Smyth, D., Croker, R., & Goldacre, B. (2018). Pregabalin. BMJ, k2318.
- Categories
Darren Smyth, Richard Croker, and Ben Goldacre explain the arguments over the patent case and explore the wider implications for the NHS and drug development